MONOCLONAL ANTIBODIES

Brand Owner (click to sort) Address Description
INNOMAB INTERNATIONAL BIOTECHNOLOGY LABORATORIES, INC. ONE KENDALL SQUARE CAMBRIDGE MA 02139 monoclonal antibodies; namely, cytoskeletal and cell surface markers for medical use;INNO-MAB;
R XOMA CORPORATION 2910 Seventh Street Berkeley CA 94710 Monoclonal Antibodies, Derivatives of Monoclonal Antibodies, Purified Toxins and Their Fragments, and Derivatives Thereof for Use In Vivo Diagnostic Use;Monoclonal Antibodies, Derivatives of Monoclonal Antibodies, Purified Toxins and Their Fragments, and Derivatives Thereof for Use in Laboratory Research;
RESEARCH & DIAGNOSTIC ANTIBODIES RESEARCH & DIAGNOSTIC ANTIBODIES P.O. Box 8300 Berkeley CA 94707 MONOCLONAL ANTIBODIES, POLYCLONAL ANTISERA, IMMUNASSAY REGENTS, AND IMMUNOASSAY KITS;
SERAVAC FINE CHEMICALS CORPORATION (PROPRIETARY) LIMITED HAWKINS AVENUE, EPPING CAPE TOWN South Africa MONOCLONAL ANTIBODIES, ENZYMES AND BIOCHEMICALS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND OF DIAGNOSTIC PRODUCTS;
UPSTATE BIOTECHNOLOGY INCORPORATED UPSTATE BIOTECHNOLOGY, INC. 199 Saranac Avenue Lake Placid NY 12946 monoclonal antibodies, polyclonal antibodies, purified recombinant proteins, purified natural proteins, fetal bovine serum, cell growth supplements, affinity purification kits, western immuno blotting kits, immunocyto chemistry kits, purified enzymes, partially purified enzymes and miscellaneous biochemicals;
XOMA XOMA CORPORATION 2910 Seventh Street Berkeley CA 94710 Monoclonal Antibodies, Derivatives of Monoclonal Antibodies, Purified Toxins and Their Fragments, and Derivatives Thereof for Use in Medical Therapy;Monoclonal Antibodies, Derivatives of Monoclonal Antibodies, Purified Toxins and Their Fragments, and Derivatives Thereof for Use in Laboratory Research;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Disclosed herein are hydridoma cell lines producing monoclonal human natural IgM antibodies and methods of use thereof. The antibodies are the monoclonal equivalents of circulating human natural antibodies. Also disclosed herein are pharmaceutical formulations and methods for treating HIV-1 infected individuals using the monoclonal human natural antibodies.